Activists slam EU-India Free Trade Agreement
February 10th, 2012 - 8:29 pm ICT by IANSNew Delhi, Feb 10 (IANS) Activists from several NGOs Friday accused the European Union (EU) of using India to bail out itself from its current economic crisis and protested the Free Trade Agreement (FTA) currently under negotiation between the two.
Arguing that the FTA would adversely affect the Indian pharmaceutical, agricultural and many other sectors, the activists termed the negotiations as secret and undemocratic, citing leaked texts from the EU.
“The harmful provisions in the agreement could have a severely negative impact on access to affordable medicine for people in developing countries. Whether we get to live or die should not be up to trade negotiators,” said Mundrika Gahlot of the Delhi Network of Positive People.
“We’re all here today with one clear message to India and the EU: Don’t trade away our lives,” added Gahlot.
According to activists, India has been called the “pharmacy of the developing world” because it produces quality affordable medicines that governments, UN agencies and the international medical humanitarian organization Medecins Sans Frontieres (MSF) rely on for the treatment of millions of people.
Due to competition among medicine producers in India, the price of first-line HIV medicines has dropped by more than 99 percent, from $10,000 per person per year in 2000 to roughly $150 today, said Shailly Gupta of MSF.
This significant price decrease has supported the massive expansion of HIV treatment worldwide.
However, existing trade rules already limit the possibility of making generic versions of new medicines, but the EU-India FTA threatens to make this situation even worse, by creating new Intellectual Property (IP) barriers.
According to Anand Grover, the director of the Lawyers Collective HIV/AIDS Unit, the EU wants India to agree to IP enforcement measures that could block medicines at Indian ports on their way to patients in other developing countries, and could even draw treatment providers into court proceedings.
“Several IP measures will affect the production, registration and distribution of affordable medicines. The EU is just using India to save itself from the economic crisis it is going through,” said activist Kanwaljit Singh.
- Trade pact with EU won't impact pharma industry: India - Dec 10, 2010
- Don't block affordable Indian medicines, EU urged - Dec 10, 2010
- 'EU-India free trade top priority for Britain' - Nov 11, 2011
- EU-India trade deal could cost lives, aid groups warn - Apr 26, 2010
- EU-India free trade talks reach decisive moment: Official - Dec 09, 2010
- India, EU firm up agenda for summit, discuss free trade - Jan 16, 2012
- HIV vaccine design program launched in India - Mar 03, 2011
- BJP asks government to rethink Eurozone pact - Feb 06, 2012
- CPI-M opposes binding pact with EU - Feb 08, 2012
- EU wants close ties with India's IT sector - Nov 22, 2011
- EU-India FTA, a case of so near yet so far - Dec 11, 2010
- Finland hopeful of EU-India trade agreement: Finnish minister - Oct 28, 2010
- India-EU trade accord on anvil, 'no compromise' on IPR (Second Lead) - Dec 10, 2010
- All is not lost on India-EU trade frontier - Dec 10, 2010
- India to continue generic drugs for HIV patients - Jul 06, 2011
Tags: activists, aids unit, anand, developing world, economic crisis, enforcement measures, free trade agreement, generic versions, grover, gupta, hiv aids, hiv medicines, hiv treatment, humanitarian organization, indian ports, massive expansion, negative impact, new medicines, trade negotiators, treatment providers